Format

Send to

Choose Destination
Rev Alerg Mex. 2014;61 Suppl 2:S118-93.

[Mexican guidelines on the diagnosis and treatment of urticaria].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, México, DF.

Abstract

in English, Spanish

BACKGROUND:

Urticaria is a disease that a fifth of the population shallsuffer once in a lifetime. Recent clinical guidelines have proposed some fundamental changes in the diagnosis and treatment of urticaria, making the development of a national, multidisciplinary guideline, with wide acceptability among different professional groups -both specialists and primary health care workers-, necessary in Mexico.

MATERIAL AND METHOD:

Internationally recognized tools for guidelinedevelopment were used. An interdisciplinary group of clinical experts (some of them knowledgeable in methodology of guideline development) determined the objectives and scope of the Evidence Based Clinical Practice Guideline with SCOPE. It was decided to adapt and transculturize international guidelines on the diagnosis and treatment of urticaria. With AGREE-II three high-quality guidelines (Zuberbier 2014, Sánchez-Borges 2012, Powell 2007) were selected to function as basic guidelines (BG). A set of Clinical Questions was formulated that lead to recommendations/suggestions, based on these BG, taking into account the cultural and economic background of Mexico, according to GRADE recommendation development.

RESULTS:

By a formal process of discussion and voting during several working-sessions, experts and first level healthcare physicians determined the wording of the final guideline, taking particularly care of developing a document, adjusted to the reality, values and preferences of the Mexican patients. The use of oral second generation, non-sedating antihistamines as first line treatment is emphasized.

CONCLUSION:

This document is an Evidence Based Clinical Practice Guideline for the diagnosis and treatment of acute and chronic urticaria, based on three, high quality, international guidelines. It was developed by a multidisciplinary group. Tables and algorithms make the guideline user-friendly for both, first line health care physicians and specialists.

KEYWORDS:

Angioedema; Antihistamine; Chronic urticaria; Clinical practice guideline; Corticosteroid; Cyclosporin; Omalizumab; Urticaria; Wheals

PMID:
25724222

Supplemental Content

Loading ...
Support Center